This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (33)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Men's Health  • Neurology  • Alert me on articles by topic  Social Bookmarking   What's this?

Molly M. Shores, MD; Alvin M. Matsumoto, MD; Kevin L. Sloan, MD; Daniel R. Kivlahan, PhD

Arch Intern Med. 2006;166:1660-1665.

Background  Low serum testosterone is a common condition in aging associated with decreased muscle mass and insulin resistance. This study evaluated whether low testosterone levels are a risk factor for mortality in male veterans.

Methods  We used a clinical database to identify men older than 40 years with repeated testosterone levels obtained from October 1, 1994, to December 31, 1999, and without diagnosed prostate cancer. A low testosterone level was a total testosterone level of less than 250 ng/dL (<8.7 nmol/L) or a free testosterone level of less than 0.75 ng/dL (<0.03 nmol/L). Men were classified as having a low testosterone level (166 [19.3%]), an equivocal testosterone level (equal number of low and normal levels) (240 [28.0%]), or a normal testosterone level (452 [52.7%]). The risk for all-cause mortality was estimated using Cox proportional hazards regression models, adjusting for demographic and clinical covariates over a follow-up of up to 8 years.

Results  Mortality in men with normal testosterone levels was 20.1% (95% confidence interval [CI], 16.2%-24.1%) vs 24.6% (95% CI, 19.2%-30.0%) in men with equivocal testosterone levels and 34.9% (95% CI, 28.5%-41.4%) in men with low testosterone levels. After adjusting for age, medical morbidity, and other clinical covariates, low testosterone levels continued to be associated with increased mortality (hazard ratio, 1.88; 95% CI, 1.34-2.63; P<.001) while equivocal testosterone levels were not significantly different from normal testosterone levels (hazard ratio, 1.38; 95% CI, 0.99%-1.92%; P=.06). In a sensitivity analysis, men who died within the first year (50 [5.8%]) were excluded to minimize the effect of acute illness, and low testosterone levels continued to be associated with elevated mortality.

Conclusions  Low testosterone levels were associated with increased mortality in male veterans. Further prospective studies are needed to examine the association between low testosterone levels and mortality.

Author Affiliations: Geriatric Research, Education, and Clinical Center (Drs Shores and Matsumoto) and Center of Excellence in Substance Abuse Treatment and Education (Drs Sloan and Kivlahan), VA Puget Sound Health Care System, Seattle, Wash, and Departments of Psychiatry and Behavioral Sciences (Drs Shores, Sloan, and Kivlahan) and Medicine (Dr Matsumoto), University of Washington, Seattle.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Testosterone therapy in men
Theodoraki and Bouloux
Menopause Int 2009;15:87-92.
ABSTRACT | FULL TEXT  

Low Serum Testosterone Increases Mortality Risk among Male Dialysis Patients
Carrero et al.
J. Am. Soc. Nephrol. 2009;20:613-620.
ABSTRACT | FULL TEXT  

Salivary Sex Hormone Measurement in a National, Population-Based Study of Older Adults
Gavrilova and Lindau
J Gerontol B Psychol Sci Soc Sci 2009;0:gbn028v1-gbn028.
ABSTRACT | FULL TEXT  

The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
Traish et al.
J Androl 2009;30:23-32.
ABSTRACT | FULL TEXT  

Testosterone deficiency--the male menopause?
Simon
InnovAiT 2008;1:625-630.
ABSTRACT | FULL TEXT  

Variation in Estrogen-Related Genes Associated with Cardiovascular Phenotypes and Circulating Estradiol, Testosterone, and Dehydroepiandrosterone Sulfate Levels
Peter et al.
J. Clin. Endocrinol. Metab. 2008;93:2779-2785.
ABSTRACT | FULL TEXT  

Low Serum Testosterone and Mortality in Older Men
Laughlin et al.
J. Clin. Endocrinol. Metab. 2008;93:68-75.
ABSTRACT | FULL TEXT  

Testosterone Making an Entry Into the Cardiometabolic World
Basaria and Dobs
Circulation 2007;116:2658-2661.
FULL TEXT  

Relationship Between Low Levels of Anabolic Hormones and 6-Year Mortality in Older Men: The Aging in the Chianti Area (InCHIANTI) Study
Maggio et al.
Arch Intern Med 2007;167:2249-2254.
ABSTRACT | FULL TEXT  

Androgen Receptor Gene CAG Repeat Length and Body Mass Index Modulate the Safety of Long-Term Intramuscular Testosterone Undecanoate Therapy in Hypogonadal Men
Zitzmann and Nieschlag
J. Clin. Endocrinol. Metab. 2007;92:3844-3853.
ABSTRACT | FULL TEXT  

Prevalence and Consequences of Androgen Deficiency in Young Male Cancer Survivors in a Controlled Cross-Sectional Study
Greenfield et al.
J. Clin. Endocrinol. Metab. 2007;92:3476-3482.
ABSTRACT | FULL TEXT  

Sex Steroids and All-Cause and Cause-Specific Mortality in Men
Araujo et al.
Arch Intern Med 2007;167:1252-1260.
ABSTRACT | FULL TEXT  

In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study
Yeap et al.
Eur J Endocrinol 2007;156:585-594.
ABSTRACT | FULL TEXT  

Medical Implications of the Male Biological Clock.
Lewis et al.
JAMA 2006;296:2369-2371.
FULL TEXT  

Endocrinology & Metabolism News, October 2006
J. Clin. Endocrinol. Metab. 2006;91:17a-17a.
FULL TEXT